Complicaciones en la trombólisis en el infarto agudo del miocardio
##plugins.themes.themeEleven.article.main##
Palabras clave
Pacientes, Infarto del Miocardio, Trombosis Coronaria, Estreptoquinasa, Enfermería
Resumen
Con el propósito de estudiarlas complicaciones que acompañan la administración de estreptocinasa intravenosa, en el infarto agudo del miocardio, se estudiaron a 67 pacientes, menores de 65 años y con menos de 6 horas de iniciada la sintomatología del episodio del infarto agudo del miocardio, administrándose 1.5 millones de unidades de estreptocinasa en una hora.
Los hallazgos fueron; en su gran mayoría sangrados menores en los sitios de instalación de punzocats, de catéter central venopunción y gingiborragia, los sangrados mayores manifestados como hematuria y de tubo digestivo se presentaron en menor cantidad, así como las reacciones alergo anafilácticas presentadas como rash, cefalea y fiebre.
Ningún paciente requirió de transfusión sanguínea, ni de la administración de esferoides, no hubo mortalidad relacionada con el procedimiento.
Referencias
DeWood MA, SpresJ, Notske R et al: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N. Eng J Med. 303:897,1980.
Reimer KA, Jennings RB. Toe wavefront phenomenon of myocardial ischemic cell death. Transmural progression of necrosis within the framework of ischemic bed. size. Lab lnvest 40: 633 1979.
Roger WJ, Hood WP Jr, Mantle JA et al. Return of left xentricular function after reperfusion in patients with myocardial infarction: Importance of subtotal stenoses or intact collateral. Circulation 69:338, 1984.
Jennings RB, Reimer KA Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood. Circulation 68-1: 25, 1983.
Mathey DG, Sheehan FH, Schofer J, DodgeHT. Timefron onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. J. Am. Coll Cardiol 6: 518,1985.
Timmis GC, Westveer DC, Hauser AM et al: Toe influence of infarction site and size on the ventricular response to coronary reperfusion. Arch Int Med 145: 2188,1985.
Anderson JL, Marshall HW, Bray Be et al: A randomized trial of intracoronary streptokinase in treatment of acute myocardial infarction. N England J MED 308: 1312, 1983.
Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Westerb Washinton randomized trial of intracoronary streptokinase inacute myocardial infarction. N Engl J Med. 309: 1477,1983.
Grupo Italiano per lo Studio della streptochinasi Nell infarcto miocardio (GISSI): Effectiveness of intravenous streptokinase thrombolytic treatment in acute myocardial infarction. I: 397, 1986.
Grupo Italiano per lo Studio della streptochinasi Nellinfarto miocárdico (GISSI). Long term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Toe lance 871-874. 1987.
Grossman W. Cardiac catheterization and angiography. Editorial LEA & Febiger Philadelphia 310-315, 1980.
Thrombolytic therapy in trombosis: A national institutes of health consensus development conference (symposiun). Ann Inter Med. 193: 141-1980.
Killp T y Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am. J. Cardiol 20: 457. 1967.
Stamler J. Toe primary prevention of coronary heart disease. In braunwald, E.: Toe myocardial failure and infarction. New York. H.P. Publishing Co. J. Inc 1974: 219.
Adgey AAJ, Geddes JS, Mulholland HC, Meegan AJ and Pantridge JF. Incidence, Signficance and management of early bradyarhytmias complicating acute myocardial infarction. Lancet 2: 1097, 1968.
Pantridge DF and Adgey AAJ. Pre-hospital coronary care. Toe mobile coronarycare unit. Am. J. Cardiol. 24: 666. 1969.
Adgey AAJ, Alley JD , Geddes JS, James RG, Webb SW and Zaidi SA Acute phase of myocardial infarction Lancet 2: 501,1971.
Graner LE, Gershen BJ, Orlando MM and Epstein SE Bradycardia and its complications in the pre-hospital phase of acute myocardial infarction. Am. J. Cardiol 32: 607, 1973.
Metzer LE and Kitchell JB. Toe incidence of arhytmias associated with acute myocardial infarction. Prog. cardiovasdis. 9: 50, 1966.
DeSanctis RWP and Hutter AM. Tachyarhytmias in myocardial infarction. Circulation 45: 681, 1972.
Adgey AJ y col. Acute phase of myocardial infarction prehospital management of coronary patients Minnesota Med. 59: 347, 1976.
Rotman M, Wagner GS and Wallace AP. Bradyarhytmias in acute myocardial infarction. Circulation. 45: 703, 1972.
Friedberg CK, Cohe H and Donoso E. Advanced heart block as a complication of acute myocardial infarction. Role of pecemaker therapy. Prog. Cardiovasc dis. 10:466, 1968.
YusufS, Collins R, Peto R, Furberg C, Stampfer M, Goldhaber S and Hennekens CH. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, re-infarction and side-effects from 33 randomized controlled trials. European Heart Journal 6: 556. 1985.